New Key Statistics Module, Z-Score and F-Score
OTCPK:IDXG Key Ratios
| Market Cap $ M | 6.81 |
| Enterprise Value $ M | 12.83 |
| P/E(ttm) | 1.99 |
| PE Ratio without NRI | 1.91 |
| Forward PE Ratio | -- |
| Price/Book | -- |
| Price/Sales | 0.16 |
| Price/Free Cash Flow | 2.20 |
| Price/Owner Earnings | 2.94 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 41.00 |
| EPS (TTM) $ | 0.78 |
| Beneish M-Score | -2.6 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | 126.60 |
| EV-to-EBIT | 3.28 |
| EV-to-EBITDA | 2.52 |
| PEG | -- |
| Shares Outstanding M | 4.39 |
| Net Margin (%) | 6.73 |
| Operating Margin % | 10.64 |
| Pre-tax Margin (%) | 7.23 |
| Quick Ratio | 0.47 |
| Current Ratio | 0.53 |
| ROA % (ttm) | 20.53 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | 54.42 |
| Dividend Yield % | -- |
| Altman Z-Score | -23.07 |
IDXG Number of Guru Trades
IDXG Volume of Guru Trades
Gurus Latest Trades with OTCPK:IDXG
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:IDXG is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Interpace Biosciences Inc Insider Transactions
No Available Data
News about OTCPK:IDXG
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers